ArthNow Logo
ArthNow
•1 min read•
✦Reported by MoneyControl

Buy Apeejay Surrendra Park Hotels; target of Rs 160: Prabhudas Lilladher

Buy Apeejay Surrendra Park Hotels; target of Rs 160: Prabhudas Lilladher
Source: MoneyControl

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓Prabhudas Lilladher issued a buy rating for Apeejay Surrendra Park Hotels with a target price of Rs 160.
  • ✓The firm reported a 7.4% revenue increase, though profits fell due to higher costs.
  • ✓The company now plans to add 18 hotels to its portfolio and grow the Flurys retail chain significantly.

Story at a Glance

Category
Indian Markets
Reported By
MoneyControl
Reading Speed
1 Minute(s)
Market Focus
India Economy

Prabhudas Lilladher's research report on Apeejay Surrendra Park Hotels PARKHOTE IN reported steady performance as revenues increased 7.4% YoY to INR1,797mn (PLe INR1,812mn) with an EBITDA margin of 30.2% (PLe 29.7%). However, PAT declined 9.7% YoY to INR146mn (PLe INR185mn) impacted by higher-thanexpected depreciation and finance costs. PARKHOTE IN intends to expand hospitality portfolio with 18 hotels comprising 879 keys in development pipeline over the next 18 months. Further, Flurys continues to scale its retail presence having expanded to 112 outlets in 1HFY27, with a target of ~300 stores by FY30E.   Outlook We expect sales/EBITDA CAGR of 14%/19% over FY26-FY29E and retain BUY with a SoTP based TP of INR160 valuing the hotel business at 11x Sep-28E EBITDA (earlier 11.5x) and Flurys at 1.5x Sep28E sales (no change in target multiple).

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

MoneyControl

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.